106 related articles for article (PubMed ID: 20118510)
21. Progress in tailoring adjuvant endocrine therapy for postmenopausal women with early breast cancer.
Bedard PL; Piccart-Gebhart MJ
Curr Opin Oncol; 2009 Nov; 21(6):491-8. PubMed ID: 19593135
[TBL] [Abstract][Full Text] [Related]
22. Are aromatase inhibitors superior to antiestrogens?
Howell A; Buzdar A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):237-47. PubMed ID: 15860266
[TBL] [Abstract][Full Text] [Related]
23. Clinical use of aromatase inhibitors in the treatment of advanced breast cancer.
Trunet PF; Vreeland F; Royce C; Chaudri HA; Cooper J; Bhatnagar AS
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):241-5. PubMed ID: 9365196
[TBL] [Abstract][Full Text] [Related]
24. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
25. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
[TBL] [Abstract][Full Text] [Related]
26. [Dual effects of androgens on mammary gland].
Brettes JP; Mathelin C
Bull Cancer; 2008 May; 95(5):495-502. PubMed ID: 18541513
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant therapy with aromatase inhibitors in postmenopausal, estrogen receptor- positive breast cancer patients: upfront or sequential?
Dediu M; Median D; Alexandru A; Vremes G; Gal C; Gongu M
J BUON; 2009; 14(3):375-9. PubMed ID: 19810126
[TBL] [Abstract][Full Text] [Related]
28. Current and future status of adjuvant therapy for breast cancer.
Coleman RE
Cancer; 2003 Feb; 97(3 Suppl):880-6. PubMed ID: 12548590
[TBL] [Abstract][Full Text] [Related]
29. Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer.
Chlebowski RT
Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():25-34. PubMed ID: 19101792
[TBL] [Abstract][Full Text] [Related]
30. Are all aromatase inhibitors alike?
Blackwell KL
Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():35-43. PubMed ID: 19101793
[TBL] [Abstract][Full Text] [Related]
31. Emerging bone health issues in women with breast cancer in Hawai'i.
Carney JF; Davis J
Hawaii Med J; 2007 Jun; 66(6):164-6. PubMed ID: 17621865
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant endocrine therapy for early breast cancer.
Andreetta C; Smith I
Cancer Lett; 2007 Jun; 251(1):17-27. PubMed ID: 17150303
[TBL] [Abstract][Full Text] [Related]
33. Aromatase inhibitors: structural features and biochemical characterization.
Hong Y; Chen S
Ann N Y Acad Sci; 2006 Nov; 1089():237-51. PubMed ID: 17261771
[TBL] [Abstract][Full Text] [Related]
34. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
Berry J
Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
[TBL] [Abstract][Full Text] [Related]
35. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
36. Aromatase inhibitors: future directions.
Osborne CK; Schiff R
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):183-7. PubMed ID: 16019204
[TBL] [Abstract][Full Text] [Related]
37. Safety of adjuvant aromatase inhibitor therapy.
Venturini M; Del Mastro L
Cancer Treat Rev; 2006 Nov; 32(7):548-56. PubMed ID: 17008013
[TBL] [Abstract][Full Text] [Related]
38. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.
Johnston SR
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s. PubMed ID: 11916228
[TBL] [Abstract][Full Text] [Related]
39. [Bone and Men's Health. The role of androgens in bone metabolism].
Ashida K; Akehi Y; Kudo T; Yanase T
Clin Calcium; 2010 Feb; 20(2):165-73. PubMed ID: 20118507
[TBL] [Abstract][Full Text] [Related]
40. New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.
Cepa M; Correia-da-Silva G; da Silva EJ; Roleira FM; Borges M; Teixeira NA
BMC Cell Biol; 2008 Jul; 9():41. PubMed ID: 18652661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]